Detalhe da pesquisa
1.
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study.
BMC Cancer
; 23(1): 416, 2023 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37158833
2.
Effectiveness and safety of lenvatinib plus anti-programmed death-1 antibodies in patients with hepatocellular carcinoma: A real-world cohort study.
Cancer Med
; 12(8): 9202-9212, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36790032
3.
The Safety Profile of Hepatectomy Following Preoperative Systemic Therapy with Lenvatinib Plus Anti-PD-1 Antibodies Versus Hepatectomy Alone in Patients With Hepatocellular Carcinoma.
Ann Surg Open
; 3(2): e163, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37601608
4.
Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis.
Biomark Res
; 9(1): 19, 2021 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743822
5.
Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations.
Liver Cancer
; 10(4): 320-329, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34414120
6.
Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma.
Hepatology
; 49(2): 460-70, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19053044
7.
Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases.
Hepatogastroenterology
; 53(68): 275-80, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16608039
8.
[Time dependency of factors influencing survival of hepatocellular carcinoma patients with portal vein tumor thrombosis after surgery].
Zhonghua Yi Xue Za Zhi
; 86(42): 3005-8, 2006 Nov 14.
Artigo
em Zh
| MEDLINE | ID: mdl-17288818
9.
Plasma microRNA, a potential biomarker for acute rejection after liver transplantation.
Transplantation
; 95(8): 991-9, 2013 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-23466638
10.
Activation of PI3K/AKT and MAPK pathway through a PDGFRß-dependent feedback loop is involved in rapamycin resistance in hepatocellular carcinoma.
PLoS One
; 7(3): e33379, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22428038
11.
An investigation of the effect of sorafenib on tumour growth and recurrence after liver cancer resection in nude mice independent of phosphorylated extracellular signal-regulated kinase levels.
Expert Opin Investig Drugs
; 20(8): 1039-45, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21671804
12.
Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma.
J Cancer Res Clin Oncol
; 135(5): 715-22, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19002496
13.
Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth.
Expert Opin Investig Drugs
; 18(11): 1595-604, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19780708